Breast cancer in situ. From pre-malignant lesion of uncertain significance to well-defined non-invasive malignant lesion. The Danish Breast Cancer Cooperative Group Register 1977–2007 revisited

References

• Nielsen M, Jensen J, Andersen J. Precancerous and cancerous breast lesions during lifetime and at autopsy: A study of 83 women. Cancer 1984; 54: 612–5
   PubMed Web of Science ®Google Scholar
• Rosen PP, Kosloff C, Lieberman PH, Adair F, Braun DW, Jr. Lobular carcinoma in situ of the breast: Detailed analysis of 99 patients with average follow-up of 24 years. Am J Surg Pathol 1978; 2: 225–51
   PubMed Web of Science ®Google Scholar
• Andersen JA. Lobular carcinoma in situ: A long-term follow-up in 52 cases. Acta Pathol Microbiol Scand Sect A 1974; 82: 519–33
   PubMedGoogle Scholar
• Fisher ER, Land SR, Fisher B, Mamounas E, Gilarski L, Wolmark N. Pathological findings from the National Surgical Adjuvant Breast and Bowel Project. Twelve-year observations concerning lobular carcinoma in situ. Cancer 2004; 100: 238–44
   PubMed Web of Science ®Google Scholar
• McCann J, Treasure P, Duffy T. Modelling the impact of detecting and treating carcinoma in situ in a breast screening programme. J Med Screen 2004; 11: 117–25
   PubMed Web of Science ®Google Scholar
• Page DL, Dupont WD, Rogers LW, Jensen RA, Schuyler PA. Continued local recurrence of carcinoma 15–25 years after a diagnosis of low grade ductal carcinoma in situ of the breast treated only by biopsy. Cancer 1995; 76: 1197–200
   PubMed Web of Science ®Google Scholar
• Fisher ER, Dignam J, Tan-Chiu E, Costantino J, Fisher B, Paik S, et al. Pathological findings from the National Surgical Adjuvant Breast Project (NSABP) eight-year update of Protocol B-17 Intraductal carcinoma. Cancer 1999; 86: 429–38
   PubMed Web of Science ®Google Scholar
• Andersen JA. Lobular carcinoma in situ of the breast. An approach to rational treatment. Cancer 1977; 39: 2597–602
   PubMed Web of Science ®Google Scholar
• Andersen JA. Lobular carcinoma in situ. A histological study of 52 cases. Acta Pathol Microbiol Scand A 1974; 82: 735–41
   PubMedGoogle Scholar
• Page DL, Dupont WD, Rogers LW, Rados MS. Atypical hyperplastic lesions of the female breast. A long-term follow-up study. Cancer 1985; 55: 2698–708
   PubMed Web of Science ®Google Scholar
• Graversen HP, Blichert-Toft M, Dyreborg U, Andersen JA. In situ carcinomas of the female breast. Incidence, clinical findings and DBCG proposals for management. Acta Oncol 1988; 27: 679–82
   PubMed Web of Science ®Google Scholar
• Ottesen GL, Graversen HP, Blichert-Toft M, Zedeler K, Andersen JA. Ductal carcinoma in situ of the female breast. Short term results of a prospective nationwide study. Am J Surg Pathol 1992; 16: 1183–96
   PubMed Web of Science ®Google Scholar
• Ottesen GL, Graversen HP, Blichert-Toft M, Zedeler K, Andersen JA. Lobular carcinoma in situ of the female breast. Short term results of a prospective nationwide study. Am J Surg Pathol 1993; 17: 14–21
   PubMedGoogle Scholar
• Ottesen GL, Graversen HP, Blichert-Toft M, Christensen IJ, Andersen JA. Carcinoma in situ of the female breast. 10 year follow-up results of a prospective nationwide study. Breast Cancer Res Treat 2000; 62: 197–210
   PubMed Web of Science ®Google Scholar
• Silverstein MJ, Poller DN, Waisman JR, Colburn WJ, Barth A, Gierson ED, et al. Prognostic classification of ductal carcinoma-in-situ. Lancet 1995; 345: 154–7
   Google Scholar
• Simpson PT, Reis-Filho JS, Gale T, Lakhani SR. Molecular evolution of breast cancer. J Pathol 2005; 205: 248–54
   PubMed Web of Science ®Google Scholar
• Ottosen GL. Carcinoma in situ of the female breast. APMIS 2003; 111(Suppl.108)1–67
   Google Scholar
• Holland R, Peterse JL, Millis RR, Eusebi V, Faverly D, van de Vijver MJ, et al. Ductal carcinoma in situ-a proposal for a new classification. Semin Diagn Pathol 1994;11:167–80.
   PubMed Web of Science ®Google Scholar
• Silverstein MJ. The University of Southern California/Van Nuys prognostic index for ductal cancinoma in situ of the breast. Am J Surg 2003; 186: 337–43
   PubMedGoogle Scholar
• Blichert-Toft M, Graversen HP, Andersen J, Dyreborg U, Green A. In situ carcinomas: A population based study on frequency, growth pattern and clinical aspects. World J Surg 1988; 2: 845–51
   Google Scholar
• Zafrani B, Fourguet A, Vilcoq JR, Legal M, Calle R. Conservative management of intraductal breast carcinoma with tumorectomy and radiation therapy. Cancer 1986; 57: 1299–301
   PubMed Web of Science ®Google Scholar
• Perry N, Broeders M, Wolf C, Tornberg S, Holland R, Karsa L. European guidelines for quality assurance in breast cancer screening and diagnosis4th ed. European Communities. 2006
   Google Scholar
• Veronesi P, Intra M, Vento AR, Naninato P, Caldarella P, Paganelli G, et al. Sentinel lymph node biopsy for localised ductal carcinoma in situ?. Breast 2005; 14: 520–2
   PubMed Web of Science ®Google Scholar
• Sloane JP, Amendoeira I, Apostolikas N, Bellocq JP, Bianchi S, Boecker W, et al. Consistency achieved by 23 European pathologists in categorizing ductal carcinoma in situ of the breast using five classifications. European Commission Working Group on Breast Screening Pathology. Hum Pathol 1998; 29: 1056–62
   PubMedGoogle Scholar
• Breast Cancer Cooperative Group EORTC, Radiotherapy Group EORTC, Bijker N, Meijnen P, Peterse JL, Bogaerts J, Van Hoorebeeck I, Julien JP, et al. Breast-conserving treatment with or without radiotherapy in ductal carcinoma-in-situ: Ten-year results of European Organisation for Research and Treatment of Cancer randomized phase III trial 10853–a study by the EORTC Breast Cancer Cooperative Group and EORTC Radiotherapy Group. J Clin Oncol 2006; 24: 3381–7
   PubMedGoogle Scholar
• Shelley Hwang E, Nyante SJ, Chen YY, Moore D, DeVries S, Korkola JE, et al. Clonality of lobular carcinoma in situ and synchronous invasive lobular carcinoma. Cancer 2004; 100: 2562–72
   PubMed Web of Science ®Google Scholar
• Reis-Filho JS, Simpson PT, Jones C, Steele D, Mackay A, Iravani M, et al. Pleomorphic lobular carcinoma of the breast: Role of comprehensive molecular pathology in characterization of an entity. J Pathol 2005; 207: 1–13
   PubMed Web of Science ®Google Scholar
• Kepple J, Henry-Tillman RS, Klimberg VS, Layeeque R, Siegel E, Westbrook K, et al. The receptor expression pattern in ductal carcinoma in situ predicts recurrence. Am J Surg 2006; 192: 68–71
   PubMedGoogle Scholar
• Fisher B, Land S, Mamounas E, Dignam J, Fisher ER, Wolmark N. Prevention of invasive breast cancer in women with ductal carcinoma in situ: an update of the national surgical adjuvant breast and bowel project experience. Semin Oncol 2001; 4: 400–18
   Google Scholar
• Barnes NLP, Khavari S, Boland GP, Cramer A, Knox F, Bundred NJ. Absence of HER4 expression predicts recurrence of ductal carcinoma in situ of the breast. Clin Cancer Res 2005; 11: 2163–68
   PubMed Web of Science ®Google Scholar
• Njor SH, Olsen AH, Bellstrøm T, Dyreborg U, Bak M, Axelsson C, et al. Mammography screening in the county of Fyn. November 1993–December 1999. APMIS 2003; Suppl ; 110(111)1–33
   Google Scholar